<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="408">
  <stage>Registered</stage>
  <submitdate>6/09/2005</submitdate>
  <approvaldate>13/09/2005</approvaldate>
  <actrnumber>ACTRN12605000374662</actrnumber>
  <trial_identification>
    <studytitle>Cognitive-behavioral interventions targeting improved adult asthma control and quality of life.</studytitle>
    <scientifictitle>Cognitive-behavioral interventions targeting improved adult asthma control and quality of life.</scientifictitle>
    <utrn />
    <trialacronym>CBT for asthma study</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Asthma</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Asthma</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Duration of intervention 4 x one hourly sessions one session per week.Randomised control trial designed to test  Cognitive behavioral interventions which will entail 1) Education about anxiety and asthma and differentiating between an asthma attack and a panic attack.2) Setting individual goals, anxiety management using slow breathing techniques and relaxation training.3) Thought management: challenging catastrophic and unhelpful thinking4) Problem solving skills, imagery and relapse prevention identifying high-risk situations.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Juniper Asthma Quality of life</outcome>
      <timepoint>Recorded pre-intervention, post-intervention and at a 3-month follow-up, the output of which will be uploaded into the study computer</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Asthma control questionnaire (ACQ), asthma related medical visits and missed days at work.</outcome>
      <timepoint>These measures will be recorded pre-intervention, post -intervention and at 3-month follow-up, the output of which will be uploaded into the study computer.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The HADS which is a measure of anxiety symptoms, depressive symptoms, and questionnaires identifying illness focused panic fears, generalized panic fears, panic symptoms</outcome>
      <timepoint>These measures will be recorded pre-intervention, post -intervention and at 3-month follow-up, the output of which will be uploaded into the study computer.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The health locus of control questionnaire identifying self-perceived ability to control asthma symptoms.</outcome>
      <timepoint>These measures will be recorded pre-intervention, post -intervention and at 3-month follow-up, the output of which will be uploaded into the study computer.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Phase one: (Questionnaire to identify people with asthma and anxiety/panic disorder. Diagnosis of asthma and an asthma related medical visit over the previous 12 months. Ability to give informed consent. Ability to read and write English. Phase two: Patients with one or more panic symptoms as identified in phase one. Significant anxiety scores on the HADS as identified in phase one. Phase three: All participants who complete the CBT intervention sessions.</inclusivecriteria>
    <inclusiveminage>15</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Phase two: Exclude if: any serious mental illness including bipolar disorder or cyclothymia evidence of psychosis or organic brain syndrome, currently involved in any psychotherapy or counseling, women who reprort being pregnant.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Educational / counselling / training</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed evelopes</concealment>
    <sequence>Computer software and blocking</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>15/08/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Woolcock Institute of Medical Research and University of Sydney</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney West Area Health Services</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Vandana Deshmukh</name>
      <address>PO Box M77
Missenden Road
Camperdown NSW 2050</address>
      <phone>+61 2 95158710</phone>
      <fax>+61 2 95505865</fax>
      <email>admin@woolcock.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Wendy Taylor</name>
      <address>PO Box M77
Missenden Road
Camperdown NSW 2050</address>
      <phone>+61 2 95156578</phone>
      <fax>+61 2 95505865</fax>
      <email>wtaylor@woolcock.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>